[PDF][PDF] Messenger RNA vaccination with α-galactosylceramide induces antitumor immunity by boosting cytotoxic and natural killer T cells

R Verbekea, I Lentackera, K Breckpotc… - cris.vub.be
… Taken together, we have developed a flexible and versatile mRNA nanoparticle platform …
, AL Yu, alphaGalactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33…

Oral lymphatic delivery of alpha-galactosylceramide and ovalbumin evokes anti-cancer immunization

P Pandey, SH Kim, L Subedi, K Mujahid, Y Kim… - Journal of Controlled …, 2023 - Elsevier
… We developed an orally delivered nanoemulsion that induces … successfully induced OVA-
and α-GalCer-mediated activation … available nanoparticles for drug delivery, the use of such …

Role of NKT cells during viral infection and the development of NKT cell-based nanovaccines

MA Khan, A Khan - Vaccines, 2021 - mdpi.com
NKT cell-activating nanoparticle-based vaccine delivery system was supported in order to
avoid the NKT cell anergy… the dendritic cells and activates iNKT cells without inducing anergy […

Harnessing NKT cells for vaccination

OK Burn, TE Pankhurst, GF Painter… - Oxford Open …, 2021 - academic.oup.com
… We also feature new studies that suggest activating NKT cells can … , the vaccines activated
NKT cells without inducing anergy. … These nanoparticles were found to induce both cellular

The adjuvant of α-galactosylceramide presented by gold nanoparticles enhances antitumor immune responses of MUC1 antigen-based tumor vaccines

Y Liu, Z Wang, F Yu, M Li, H Zhu, K Wang… - International Journal …, 2021 - Taylor & Francis
… gold nanoparticles was performed under gentle conditions, no … of the prepared vaccines to
induce the activation of DCs, the … reason was that NKT cell anergy might be induced when a …

Sustained release system from PLGA particles co-encapsulated with inactivated influenza virus with natural killer T cell agonist α-galactosylceramide

Y Wen, Z Sparks, I Hawkins, J Lednicky… - European Journal of …, 2024 - Elsevier
… natural killer T (NKT) cell agonist alpha-galactosylceramide (α-… inactivated influenza virus
loaded nanoparticles and soluble α-… cells to become anergic, which occurs when NKT cells are …

Using agonists for iNKT cells in cancer therapy

GF Painter, OK Burn, IF Hermans - Molecular Immunology, 2021 - Elsevier
… Type I NKT cells are commonly referred to as invariant NKT (… attributes of iNKT cell activity in
mice, including iNKT anergy, the … killer T-cell ligand alpha-galactosylceramide (KRN7000) in …

Glycolipid-containing nanoparticle vaccine engages invariant NKT cells to enhance humoral protection against systemic bacterial infection but abrogates T …

T Shute, E Amiel, N Alam, JL Yates… - The Journal of …, 2021 - journals.aai.org
… -loaded nanoP significantly activate iNKT cells in vivo without inducing anergy, we next …
simultaneously in a nanoP formulation can induce B cell activation to generate a high-titer …

Recruiting natural killer T cells to improve vaccination: Lessons from preclinical and clinical studies

OK Burn, N Dasyam, IF Hermans - Critical Reviews™ in …, 2024 - dl.begellhouse.com
… A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in …
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy

[HTML][HTML] Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

S Meulewaeter, I Aernout, J Deprez, Y Engelen… - Journal of Controlled …, 2024 - Elsevier
… conditions for induction of both humoral and cellular immunity … lipoplexes (LPXs) or lipid
nanoparticles (LNPs) were evaluated … This phenomenon often referred to as iNKT cell anergy is …